THBD and neoplasm: The thrombomodulin–fibronectin interaction occurs on tumour blood vessels in murine melanoma suggesting that this interplay may serve as a putative target for antiangiogenic therapy, although an in‐depth understanding of this interaction in healthy tissues would first need to be considered.